A novel monoclonal antibody to Neisseria meningitidis serogroup X capsular polysaccharide and its potential use in quantitation of meningococcal vaccines
- PMID: 25218518
- DOI: 10.1016/j.biologicals.2014.08.001
A novel monoclonal antibody to Neisseria meningitidis serogroup X capsular polysaccharide and its potential use in quantitation of meningococcal vaccines
Abstract
A novel murine hybridoma monoclonal antibody (MAb) was produced against the capsular polysaccharide (CP) of Neisseria meningitidis serogroup X (MenX) in order to develop a sandwich enzyme linked immunosorbent assay (ELISA) for the quantitation of the meningococcal polysaccharide. The MAb only reacted with the CP from MenX and did not react with CPs from N. meningitidis serogroups A, C, Y and W (MenA, MenC, MenY, MenW). The affinity constant (Ka) of the MAb measured by non-competitive ELISA was 7.25 × 10(7) M(-1). The application of this MAb in a sandwich ELISA was demonstrated by its ability to properly quantitate three lots of an experimental meningococcal CP-based vaccine. The MAb obtained in this work could be a valuable reagent for the detection and quantitation of future meningococcal vaccines containing MenX CP.
Keywords: ELISA; Monoclonal antibody; Neisseria meningitidis serogroup X; Quantitation.
Copyright © 2014 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.Biologicals. 2013 Jul;41(4):275-8. doi: 10.1016/j.biologicals.2013.05.002. Epub 2013 Jun 20. Biologicals. 2013. PMID: 23791517
-
Development of four sandwich ELISAs for quantitation of capsular polysaccharides from Neisseria meningitidis serogroups A, C, W and Y in multivalent vaccines.J Immunol Methods. 2014 May;407:58-62. doi: 10.1016/j.jim.2014.03.020. Epub 2014 Apr 12. J Immunol Methods. 2014. PMID: 24727145
-
Relative stability of meningococcal serogroup A and X polysaccharides.Vaccine. 2012 Oct 5;30(45):6409-15. doi: 10.1016/j.vaccine.2012.08.021. Epub 2012 Aug 22. Vaccine. 2012. PMID: 22921741
-
Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease.FEMS Immunol Med Microbiol. 1999 Dec;26(3-4):209-26. doi: 10.1111/j.1574-695X.1999.tb01392.x. FEMS Immunol Med Microbiol. 1999. PMID: 10575132 Review.
-
[Meningococcal vaccines: present status and perspectives].Therapie. 2005 May-Jun;60(3):283-6. doi: 10.2515/therapie:2005037. Therapie. 2005. PMID: 16128272 Review. French.
Cited by
-
Elucidating the Structural and Minimal Protective Epitope of the Serogroup X Meningococcal Capsular Polysaccharide.Front Mol Biosci. 2021 Oct 14;8:745360. doi: 10.3389/fmolb.2021.745360. eCollection 2021. Front Mol Biosci. 2021. PMID: 34722634 Free PMC article.
-
Establishment of Sandwich ELISA for Quality Control in Rotavirus Vaccine Production.Vaccines (Basel). 2022 Feb 5;10(2):243. doi: 10.3390/vaccines10020243. Vaccines (Basel). 2022. PMID: 35214701 Free PMC article.
-
A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A.Nat Commun. 2020 Sep 7;11(1):4434. doi: 10.1038/s41467-020-18279-x. Nat Commun. 2020. PMID: 32895393 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous